Emergency: 911 Crisis line: call or text 988 NYC Well: 888-692-9355 SAMHSA: 1-800-662-4357

New York City Drug Overdose Statistics

New York City recorded 2,192 overdose deaths in 2024 — a 28% decline from 3,056 in 2023. (Source: NYC Mayor's Office / DOHMH, October 2025.) It was the first substantial decrease in nearly a decade, and evidence that treatment — when people can access it — works.

The numbers are trending in the right direction. But 2,192 deaths in a single year still means roughly six New Yorkers dying every day. Understanding who is most at risk, which substances are driving deaths, and what the city is doing about it can help individuals and families make urgent, informed decisions about treatment.

NYC Overdose Deaths: 2024 Data

The 2024 figure of 2,192 deaths represents a 28% drop from 3,056 in 2023 — itself a slight decline from a peak period that followed four consecutive years of increases. New York State as a whole recorded 4,567 overdose deaths in 2024, down 32% from 6,688 in 2023. (Source: CDC provisional data via Healthbeat.)

The city has distributed more than 440,000 naloxone kits and 63,000 fentanyl test kits since January 2023 — harm reduction efforts that public health experts credit as a partial driver of the decline. New York City has also received nearly $190 million in opioid settlement funds through FY 2025, with more than $550 million expected by 2041. (Source: NYC Mayor's Office, October 2025.)

2,192
NYC overdose deaths in 2024 — down 28% from 3,056 in 2023

Overdose Deaths by Borough

Overdose deaths are not evenly distributed across New York City. The Bronx bears a disproportionate burden, with death rates more than double those of Manhattan and Queens. (Source: NYC DOHMH Epi Data Brief No. 142, October 2024.)

Borough Deaths per 100,000 residents (2023)
Bronx 78.0
Staten Island 40.1
Manhattan 36.0
Brooklyn 32.9
Queens 24.5

Within the Bronx, the neighborhoods of Hunts Point-Mott Haven, Crotona-Tremont, Highbridge-Morrisania, East Harlem, and Fordham-Bronx Park have recorded the highest fatal overdose rates for three consecutive years. These are communities where the concentration of poverty, housing instability, and limited treatment access amplifies risk.

Critically, approximately 70% of NYC overdose deaths occur inside a residence — not on the street or in public spaces. (Source: NYC DOHMH.) This means the most dangerous environment for a person in active addiction is often their own home — which is precisely why inpatient treatment, which removes someone from that environment entirely, is the evidence-based intervention for moderate-to-severe addiction.

If you're ready to talk about treatment options, we're available 24/7 — Call (347) 774-4506 — confidential, no obligation.

Which Substances Are Driving Overdose Deaths?

Fentanyl is the dominant substance in NYC's drug supply and the primary driver of overdose mortality. In 2024, fentanyl was detected in 73% of all NYC overdose deaths — down from 80% in 2023, but still present in nearly three out of every four deaths. (Source: NYC Special Narcotics Prosecutor.)

A growing and underreported threat is xylazine — a veterinary sedative that is not an opioid but is increasingly mixed into fentanyl supplies. Xylazine was present in 21% of NYC overdose deaths in 2024. Because xylazine is not an opioid, naloxone (Narcan) cannot fully reverse its effects. A person who has overdosed on a fentanyl-xylazine mixture may partially respond to naloxone but remain sedated — creating a dangerous window during which bystanders may believe the overdose has been reversed when it has not.

Statewide, approximately 77% of New York State overdose deaths in 2024 involved an opioid of some kind — confirming that opioids remain the central driver of overdose mortality across the state, not just New York City.

Cocaine and stimulants also contribute to overdose deaths, particularly when contaminated with fentanyl. NYC DOHMH has flagged fentanyl-contaminated cocaine as a significant and growing overdose driver. Many individuals who overdose on cocaine were not knowingly using opioids.

Who Is Most at Risk in New York City?

Overdose deaths are concentrated among specific populations:

  • Bronx residents face the highest per-capita overdose death rate in the city (78.0 per 100,000), more than three times the rate in Queens.
  • Black and Latino New Yorkers die from overdose at approximately twice the rate of white residents, even as 2024 saw a 29% decrease in overdose deaths among Black New Yorkers. Racial disparities in access to treatment and health insurance remain a key driver. (Source: Healthbeat, May 2025.)
  • People using alone at home — since roughly 70% of NYC overdose deaths occur inside a residence, individuals without others present when they use face no chance of reversal if an overdose occurs.
  • Adults aged 55–64 have shown increasing overdose death rates in recent years, reflecting the aging of the population that came of age during the prescription opioid crisis of the late 1990s and 2000s.

What Is New York City Doing About the Overdose Crisis?

New York City has deployed a range of public health interventions in response to the overdose crisis:

  • Naloxone distribution: More than 440,000 naloxone kits distributed since January 2023. Narcan is available free at NYC pharmacies without a prescription and through vending machines citywide.
  • NYC Relay Program: An emergency department-based nonfatal overdose response program that has served more than 9,883 individuals between 2017 and 2023, connecting overdose survivors to treatment and support services in the immediate aftermath of a non-fatal overdose.
  • Overdose Prevention Centers (OPCs): Two city-operated supervised consumption sites — located at 360 W. 125th St. in Harlem and 126 E. 174th St. in the Bronx — where people can use pre-obtained substances under medical supervision. These are the first legally authorized OPCs in the United States.
  • Fentanyl test kits: More than 63,000 distributed since January 2023, allowing people who use drugs to test their supply before use.
  • Opioid settlement funding: NYC has received nearly $190 million in opioid settlement funds through FY 2025, with $550 million+ expected by 2041 — funding that is legally required to go toward addiction treatment and overdose prevention programs.

These efforts have contributed to the 28% decline in overdose deaths in 2024. But harm reduction alone is not treatment. For individuals with moderate-to-severe opioid or alcohol use disorder, inpatient treatment — medically supervised detox followed by structured residential rehab — remains the clinical standard of care.

How to Get Help: Treatment and Crisis Resources

If you or a family member is in active addiction, understanding the numbers is one thing. Taking the next step is another. The resources below are available immediately and at no cost:

  • 988 Suicide & Crisis Lifeline: Call or text 988 — covers substance use crises, 24/7
  • NYC Well: 888-692-9355 — 24/7 multilingual crisis and mental health line (200+ languages)
  • SAMHSA National Helpline: 1-800-662-4357 — free, confidential, 24/7 treatment referral
  • OASAS Treatment Locator: findaddictiontreatment.ny.gov

For adults with private PPO insurance, inpatient rehab is typically a covered benefit — and the average cost of a 30-day program in New York is $56,653 without coverage. With PPO insurance, most or all of that cost can be covered. A placement advisor can verify your benefits in about 15 minutes.

Learn more about how insurance covers inpatient rehab in New York, or explore the full range of addiction resources in New York City. For fentanyl-specific treatment information, see the fentanyl rehab page. For general inpatient treatment, see inpatient drug rehab in NYC.

NYC Overdose Statistics: Common Questions

CALL NOW